Working… Menu
Trial record 1 of 1 for:    NCT01730638
Previous Study | Return to List | Next Study

ImmunoTEP for Patients With Medullary Thyroid Carcinoma. (iTEP-CMT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01730638
Recruitment Status : Completed
First Posted : November 21, 2012
Last Update Posted : March 30, 2018
Institut National de la Santé Et de la Recherche Médicale, France
Gilead Sciences
Information provided by (Responsible Party):
Nantes University Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2016
Actual Study Completion Date : December 2016